CDKN2A hypermethylation correlates with tumor progression, metastasis, and overall survival, thus representing a promising diagnostic and prognostic biomarker in HNSCC (head and neck squamous cell carcinoma) [58]. Here, CDKN2A is linked to neoplasm.